THE ESSENTIALS IN 30 SECONDS
- Oura will pay $625 million in cash for Counsel Health, subject to price adjustments and customary closing conditions, with completion expected around the end of 2026.
- Counsel combines an AI system that takes medical histories and answers health questions with licensed physicians who can diagnose, prescribe and order labs.
- Oura plans to offer Counsel inside its app and let physicians see ring data with members' permission; Counsel will keep serving health plans and systems.
Oura, the company behind the Oura smart ring, announced on 10 November that it has signed a definitive agreement to acquire Counsel Health, a startup that pairs medical AI with supervising physicians. Oura's own announcement does not give a price, but MedTech Dive reports that the company will pay $625 million in cash, subject to purchase price adjustments and customary closing conditions. Oura expects the deal to close around the end of 2026.
What Counsel does
Counsel, founded and led by physician Muthu Alagappan, describes itself as an AI-native care platform. Users begin by chatting with an AI system that, according to MedTech Dive, relies on agents to take a medical history, look up clinical guidelines, review records and spot emergencies. Patients can then bring a licensed physician into the conversation, who can diagnose, prescribe, order lab tests or make referrals. Oura notes that the service is not meant for medical emergencies.
The two companies already know each other. Oura says it has partnered with Counsel since May 2026, and its members can currently try the service through Oura Labs. According to Oura, more than half of Counsel users in Oura Labs have shared their ring data with their physicians.
How Oura plans to use it
After closing, Oura intends to offer Counsel's care inside the Oura app, positioning the ring as the source of body signals, the app as the place for insights and Counsel as the route to clinical care. Physicians would see Oura data and earlier conversations only when a member allows it, the company says. Counsel will also continue to work with health plans and health systems, including for people who do not own an Oura ring. Alagappan said in a statement that continuous health data makes medical AI "more useful and relevant to each person."
Context and open questions
The deal fits a broader push by Oura into health services; MedTech Dive points to its partnerships with medtech companies ResMed and Dexcom. It also comes after Oura sought to raise up to $2.2 billion in an initial public offering in September 2026, then postponed it later that month, citing market uncertainty.
Several details remain undisclosed, including Counsel's user numbers, where its physicians are licensed to practise, how pricing for members will work once the service moves into the Oura app, and whether the deal needs regulatory review. Oura says it will share more about the integrated experience after the acquisition closes.
